#Retinai
October 16, 2025 at 6:39 AM
Feed: "Medical Device Network"
By: gullapalli on Thursday, May 1, 2025
RetinAI and FVS’ retinopathy screening algorithm gains CE-MDR certification
LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) screening.
www.medicaldevice-network.com
May 1, 2025 at 9:07 PM
Carlos Ciller (RetinAI) : RetinAI, l'IA pour mieux diagnostiquer - 14/04

Carlos Ciller, président directeur général de RetinAI, était l'invité de François Sorel dans Tech & Co, la quotidienne, ce mardi 14 avril. Il s'est penché sur la technologie de RetinAI appliquée au domaine...
Carlos Ciller (RetinAI) : RetinAI, l'IA pour mieux diagnostiquer - 14/04
VIDÉO - Carlos Ciller, président directeur général de RetinAI, était l'invité de François Sorel dans Tech & Co, la quotidienne, ce mardi 14 avril. Il s'est penché sur la technologie de RetinAI appliqu...
www.bfmtv.com
April 14, 2026 at 7:57 PM
Ophthopedia Update: EssilorLuxottica acquires eye care software company RetinAI: Editor’s note: This is a developing news story. Please check back soon for updates.
EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss… #ophthalmology #eye #eyenews
EssilorLuxottica acquires eye care software company RetinAI
Editor’s note: This is a developing news story. Please check back soon for updates. EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing business under the name RetinAI, according to a press release. The company’s flagship product is RetinAI Discovery, a clinical software platform for managing patient data and imagery, with AI-based disease monitoring capabilities. It also makes Discovery Unity, another data management platform geared toward clinical studies and pharmaceutical research and development. “RetinAI
dlvr.it
October 16, 2025 at 3:12 PM
Ophthopedia Update: EssilorLuxottica acquires eye care software company RetinAI: Editor’s note: This is a developing news story. Please check back soon for updates.
EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing…
EssilorLuxottica acquires eye care software company RetinAI
Editor’s note: This is a developing news story. Please check back soon for updates. EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing business under the name RetinAI, according to a press release. The company’s flagship product is RetinAI Discovery, a clinical software platform for managing patient data and imagery, with AI-based disease monitoring capabilities. It also makes Discovery Unity, another data management platform geared toward clinical studies and pharmaceutical research and development. “RetinAI
dlvr.it
October 16, 2025 at 3:12 PM